Back to Journals » OncoTargets and Therapy » Volume 6

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Total article views   HTML views PDF downloads Totals
19,593 Dovepress* 12,318+ 2,127 14,445
PubMed Central* 7,275 1,540 8,815
Totals 19,593 3,667 23,260
*Since 14 February 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
26 1 0 0 3 22

View citations on PubMed Central and Google Scholar